Gestational Diabetes: Continued Controversies
Gestational diabetes mellitus (GDM) affects approximately 300,000 women annually. The proposed International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria would increase this number significantly. Mark B. Landon, M.D., discusses appropriate fetal surveillance in GDM patients and how to integrate the use of dietary therapy, exercise, the indications for insulin and oral hypoglycemic agents and strategies for monitoring maternal glucose control.
Obstetricians, Gynecologists, General Surgeons, General Practitioners, Family Physicians, Pediatricians, Oncologists, Physician Assistants, Nurse Practitioners, Nurse Midwives and all other interested healthcare professionals.
- Describe the metabolic changes in pregnancy that produce a “diabetogenic stress” and insulin resistance.
- Identify the short- and long-term morbidities for the woman with GDM and her infant.
- Construct an algorithm to detect GDM using methods currently recommended for screening and diagnosis.
- Integrate the use of dietary therapy, exercise, the indications for insulin and oral hypoglycemic agents and strategies for monitoring maternal glucose control.
Mark B. Landon, M.D.
Richard L. Meiling Professor and Chair
Department of Obstetrics and Gynecology
The Ohio State University Wexner Medical Center
Mark B. Landon, M.D., faculty for this educational activity, has no relevant financial relationship with ineligible companies* to disclose and has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Jason S. James, M.D., FACOG, indicated that he is an employee/owner of Cord Blood Registry and is on the speakers' bureau for Hologic, AMAG Pharmaceuticals and Duchesnay USA.
All of the relevant financial relationships listed for this individual has been mitigated.
James Esserman, M.D., Maria Victoria Lopez-Beecham, M.D., Dibe Martin, M.D., Rene Paez, M.D., and Larry S. Spiegelman, M.D., have no relevant financial relationship with ineligible companies* to disclose.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
This site is supported on the most recent stable releases of the following browsers:
This site is supported on the following mobile devices:
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.